Dr. Reddy's Laboratories informs about completion of auditing

29 Jan 2020 Evaluate
Dr. Reddy's Laboratories has informed that the audit of its API manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI), by the US FDA, has been completed on January 28, 2020. The company has been issued a Form 483 with 5 observations. It will address them comprehensively within the stipulated timeline.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1302.35 -10.70 (-0.81%)
06-Mar-2026 10:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.60
Dr. Reddys Lab 1302.35
Cipla 1329.25
Zydus Lifesciences 912.55
Lupin 2342.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×